Chu Xiao-xia, Hou Ming, Zhu Yuan-yuan, Peng Jun, Ji Xue-bin, Zhang Feng, Wang Lin
Department of Hematology Qilu Hospital of Shandong University, Jinan 250012, China.
Zhonghua Yi Xue Za Zhi. 2005 Dec 28;85(49):3464-8.
To study the immunoreactivity of the specific anti-platelet glycoprotein (GP) IgG antibody and its F(ab')2 fragments from patients with chronic idiopathic thrombocytopenic purpura (ITP) and to investigate their effects on platelet aggregation function.
Peripheral blood samples were collected from 84 patients with ITP. Modified monoclonal antibody immobilization of platelet antigen assays was used to detect the IgG antibodies specific for GP I b/II a, GP I b/IX and GP VI. The IgG antibody and its F(ab')2 fragments in the positive plasma inhibiting platelet aggregation function were prepared and purified. Plate-rich Peripheral blood sample was collected from a normal person with O type blood and platelet-rich plasma (PRP) and platelet-poor plasma (PPP) were prepared. Plasma pf ITP patient or purified IgG or F(ab')2 fragments of different concentrations were added into PRP, and then inducers of platelet aggregation ADP, ristocetin, or collagen were added. The platelet aggregation was measured. Platelet GP II b/III a specific human-rat chimeric antibody 7E3 and GP I b specific antibody SZ2 were used as positive controls and PBS was used as negative control.
GP II b/III a and/or GP I b/IX and/or GP VI specific antibodies were found in 48 (57.1%) patients. The plasma, purified IgG and F(ab')2 fragments of 7 of these 48 patients (14.6%) with positive autoantibody showed significant activity against GP II b/III a (4 patients), GP I b/IX (2 patients), or GP VI (one patient). The purified IgG and F(ab')2 fragments of 2 patients positive in GP II b/ III a autoantibody out of the 7 patients significantly inhibited the platelet aggregation induced by ADP, the purified IgG and F(ab')2 fragments of 1 patients positive in GP I b/IX out of the 7 patients significantly inhibited the platelet aggregation induced by ristocetin, and the purified IgG and F(ab')2 fragments of 1 patients positive in GP VI out of the 7 patients significantly inhibited the platelet aggregation induced by collagen.
A functional fragment, F(ab')2 portion of IgG is responsible for the autoantibody interaction with platelet GPs in ITP, and some of them also affect the platelet function. It can be used to develop completely humanized anti-GP small molecular phage antibody.
研究慢性特发性血小板减少性紫癜(ITP)患者特异性抗血小板糖蛋白(GP)IgG抗体及其F(ab')2片段的免疫反应性,并探讨其对血小板聚集功能的影响。
采集84例ITP患者的外周血样本。采用改良的单克隆抗体固定血小板抗原分析法检测针对GP I b/II a、GP I b/IX和GP VI的IgG抗体。制备并纯化阳性血浆中抑制血小板聚集功能的IgG抗体及其F(ab')2片段。采集一名O型血正常人的外周血样本,制备富含血小板血浆(PRP)和乏血小板血浆(PPP)。将ITP患者血浆或不同浓度的纯化IgG或F(ab')2片段加入PRP中,然后加入血小板聚集诱导剂ADP、瑞斯托霉素或胶原。检测血小板聚集情况。血小板GP II b/III a特异性人鼠嵌合抗体7E3和GP I b特异性抗体SZ2作为阳性对照,PBS作为阴性对照。
48例(57.1%)患者检测到GP II b/III a和/或GP I b/IX和/或GP VI特异性抗体。这48例自身抗体阳性患者中的7例(14.6%)的血浆、纯化IgG和F(ab')2片段对GP II b/III a(4例)、GP I b/IX(2例)或GP VI(1例)显示出显著活性。7例患者中2例GP II b/III a自身抗体阳性患者的纯化IgG和F(ab')2片段显著抑制ADP诱导的血小板聚集,7例患者中1例GP I b/IX阳性患者的纯化IgG和F(ab')2片段显著抑制瑞斯托霉素诱导的血小板聚集,7例患者中1例GP VI阳性患者的纯化IgG和F(ab')2片段显著抑制胶原诱导的血小板聚集。
IgG的功能性片段F(ab')2部分负责ITP中自身抗体与血小板GP的相互作用,其中一些还影响血小板功能。它可用于开发完全人源化的抗GP小分子噬菌体抗体。